ECSP993021A - THERAPEUTIC COMBINATIONS FOR MUSCULOSKELETAL FRAGILITY - Google Patents
THERAPEUTIC COMBINATIONS FOR MUSCULOSKELETAL FRAGILITYInfo
- Publication number
- ECSP993021A ECSP993021A ECSP993021A ECSP993021A EC SP993021 A ECSP993021 A EC SP993021A EC SP993021 A ECSP993021 A EC SP993021A EC SP993021 A ECSP993021 A EC SP993021A
- Authority
- EC
- Ecuador
- Prior art keywords
- compositions
- fragility
- pyridin
- oxo
- phenyl
- Prior art date
Links
Abstract
Esta invención se refiere a composiciones farmacéuticas de combinación y a procedimientos que comprenden (-) -cis-6-fenil-5-(4-(2-pirrolidin-1-il-etoxi)-fenil-5,6,7,8-tetrahidronaftalen-2-ol, o una sal farmacéuticamente aceptables del mismo y 2-amino-N-(1(R)-(2,4-difluoro-benciloximetil)2-oxo-2-(3-oxo-3a(R) - piridin - 2-ilmetil)-2-(2,2,2 -trifluoro-etil)-2,3,3a,4,6,7, -hexahidro-pirazolo (4,3 -C(piridin -5-il)-etil)2-metil- propionamida o una sal farmacéuticamente aceptable de la misma, a procedimientos de uso de tales composiciones y a estuches que contiene tales composiciones. Las composiciones son útiles para el tratamiento de la fragilidad musculoesquelética; incluyendo la osteoporosis, fracturas osteoporóticas, reducción de masa ósea, fragilidad y reducción de masa muscular.This invention relates to combination pharmaceutical compositions and processes comprising (-) -cis-6-phenyl-5- (4- (2-pyrrolidin-1-yl-ethoxy) -phenyl-5,6,7,8- tetrahydronaphthalen-2-ol, or a pharmaceutically acceptable salt thereof and 2-amino-N- (1 (R) - (2,4-difluoro-benzyloxymethyl) 2-oxo-2- (3-oxo-3a (R) - pyridin-2-ylmethyl) -2- (2,2,2 -trifluoro-ethyl) -2,3,3a, 4,6,7, -hexahydro-pyrazolo (4,3 -C (pyridin -5-yl ) -ethyl) 2-methyl-propionamide or a pharmaceutically acceptable salt thereof, to methods of using such compositions and to kits containing such compositions The compositions are useful for the treatment of musculoskeletal fragility, including osteoporosis, osteoporotic fractures , reduction of bone mass, fragility and reduction of muscle mass.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993021 ECSP993021A (en) | 1999-06-16 | 1999-06-16 | THERAPEUTIC COMBINATIONS FOR MUSCULOSKELETAL FRAGILITY |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993021 ECSP993021A (en) | 1999-06-16 | 1999-06-16 | THERAPEUTIC COMBINATIONS FOR MUSCULOSKELETAL FRAGILITY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP993021A true ECSP993021A (en) | 1999-08-12 |
Family
ID=42044010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP993021 ECSP993021A (en) | 1999-06-16 | 1999-06-16 | THERAPEUTIC COMBINATIONS FOR MUSCULOSKELETAL FRAGILITY |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP993021A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11723902B2 (en) | 2014-09-04 | 2023-08-15 | Helsinn Healthcare Sa | Medical treatments based on anamorelin |
-
1999
- 1999-06-16 EC ECSP993021 patent/ECSP993021A/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11723902B2 (en) | 2014-09-04 | 2023-08-15 | Helsinn Healthcare Sa | Medical treatments based on anamorelin |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1348709A3 (en) | Thiazolo (4,5-D) pyrimidine compounds | |
| HK1080459A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
| PT991653E (en) | NEW COMPOUNDS | |
| CA2400217A1 (en) | Pteridine compounds for the treatment of psoriasis | |
| BR0309875A (en) | methods and compositions for treating peripheral nervous system disorders and novel compounds useful therefor | |
| WO2003048164A3 (en) | Adenosine a2a receptor antagonists | |
| UY25557A1 (en) | THERAPEUTIC COMBINATIONS FOR MUSCULOSKELETAL FRAGILITY | |
| MXPA03000439A (en) | Novel form of (r)-n-[5- methyl-8-(4- methylpiperazin-1-yl) -1, 2, 3, 4-tetrahydro -2-naphthyl] -4-morpholinobenzamide. | |
| AR018869A1 (en) | PHARMACEUTICAL COMPOSITION, ITS USE FOR THE PREPARATION OF MEDICINES AND CASE THAT CONTAINS IT | |
| ECSP993021A (en) | THERAPEUTIC COMBINATIONS FOR MUSCULOSKELETAL FRAGILITY | |
| PL368040A1 (en) | Substituted 4-aminocyclohexanol derivatives | |
| ECSP993020A (en) | COMBINATION THERAPY FOR MUSCULOSKELETAL FRAGILITY | |
| WO2002076930A3 (en) | Substituted diarylureas as stimulators for fas-mediated apoptosis | |
| SE0100296D0 (en) | New compounds | |
| SE0100295D0 (en) | New compounds | |
| HUP0103544A2 (en) | Pharmaceutical composition containing (r)-3-n,n-dicyklobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxamide hidrogen-(2r,3r)tartarate monohydrate and paroxetin and process for its preparation | |
| GB9211277D0 (en) | Pharmaceutical compositions |